The Sequencing Conundrum in Metastatic Castrate-resistant Prostate Cancer (mCRPC): the Rosemere Cancer Centre Experience to Unlocking the Optimal Sequence

被引：0
|
作者：
Pan, S. [1 ]
Kumar, V. [1 ]
Charnley, N. [1 ]
Parikh, O. [1 ]
Birtle, A. [1 ]
机构：
[1] Royal Preston Hosp, Rosemere Canc Ctr, Preston, Lancs, England
来源：
CLINICAL ONCOLOGY | 2016年 / 28卷 / 05期
关键词：
D O I：
10.1016/j.clon.2015.12.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E14 / E14
页数：1
相关论文
共 50 条
  • [1] The sequencing conundrum in metastatic castrate resistant prostate cancer (mCRPC): The Rosemere Cancer Centre experience to unlocking the optimal sequence
    Pan, S.
    Kumar, V.
    Parikh, O.
    Charnley, N.
    Birtle, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 74 - 75
  • [2] Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
    Karnes, R. Jeffrey
    Ahmed, Mohamed E.
    APPLIED RADIOLOGY, 2021, 50 (01) : 42 - 43
  • [3] Treatment sequencing in metastatic castrate-resistant prostate cancer
    Sartor, Oliver
    Gillessen, Silke
    ASIAN JOURNAL OF ANDROLOGY, 2014, 16 (03) : 426 - 431
  • [4] Next Generation Sequencing in metastatic castrate-resistant prostate cancer
    Adashek, Jacob J.
    Salgia, Meghan
    Pal, Sumanta K.
    UROLOGY CASE REPORTS, 2018, 19 : 60 - 62
  • [5] Metastatic castrate-resistant prostate cancer
    Schellhammer, Paul
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (01) : 51 - 52
  • [6] Exosomal microRNA as prognostic biomarkers in metastatic castrate-resistant prostate cancer (mCRPC).
    Kohli, Manish
    Huang, Xiaoyi
    Yuan, Tiezheng
    Sun, Zhifu
    Costello, Brian Addis
    Quevedo, Fernando
    Tan, Winston
    Nandy, Debashis
    Longenbach, Sherri
    Wang, Liang
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [7] Impact of comorbidity on outcome in men with metastatic castrate-resistant prostate cancer (mCRPC)
    Zist, A.
    Amir, E.
    Ocana, A.
    Seruga, B.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S703 - S703
  • [8] Enzalutamide after abiraterone in patients with metastatic castrate-resistant prostate cancer (mCRPC).
    Sandhu, Gurprataap Singh
    Parikh, Rahul Atul
    Appleman, Leonard Joseph
    Friedland, David
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [9] Pembrolizumab (pembro) in heavily pretreated metastatic castrate-resistant prostate cancer (mCRPC).
    Moses, Marcus Marie
    Ledet, Elisa
    Manogue, Charlotte
    Lewis, Brian E.
    Barata, Pedro C.
    Sartor, A. Oliver
    Layton, Jodi Lyn
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [10] AUSTRALIAN EXPERIENCE WITH CABAZITAXEL IN METASTATIC CASTRATE RESISTANT PROSTATE CANCER (mCRPC)
    Ng, S.
    Gurney, H.
    Parente, P.
    Bahre, M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 63 - 63
12345